Ha seleccionado la visión en Inglés
Descriptor en español: |
Factor de Activación Plaquetaria
| ||||||
Descriptor en inglés: | Platelet Activating Factor | ||||||
Descriptor en portugués: | Fator de Ativação de Plaquetas | ||||||
Descriptor en francés: | Facteur d'activation plaquettaire | ||||||
Término(s) alternativo(s): |
1 Alkyl 2 acetyl sn glycerophosphocholine 1-Alkyl-2-acetyl-sn-glycerophosphocholine AGEPC Acetyl Glyceryl Ether Phosphorylcholine Aggregating Factor, Platelet Factor, Platelet Activating PAF Acether PAF-Acether Phosphorylcholine, Acetyl Glyceryl Ether Platelet Activating Substance Platelet Aggregating Factor Platelet Aggregation Enhancing Factor Platelet-Activating Substance Thrombocyte Aggregating Activity |
||||||
Código(s) jeráquico(s): |
D02.033.100.291.211.500 D02.092.063.291.211.500 D02.092.877.883.333.710 D02.675.276.232.710 D10.570.755.375.760.400.985.910 D23.119.865 D23.469.050.600 |
||||||
Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D010972 | ||||||
Nota de alcance: | A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. |
||||||
Calificadores permitidos: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Indexación anterior: |
Lysophosphatidylcholines (1966-1980) |
||||||
Nota Pública de MeSH: | 1983; PLATELET AGGREGATING FACTOR was indexed under PLATLET ACTIVATING FACTOR 2002-2005 & BLOOD COAGULATION FACTORS 1979-2001 |
||||||
Nota de historia: | 1983(1979) |
||||||
Identificador de DeCS: | 23518 | ||||||
ID del Descriptor: | D010972 | ||||||
Documentos indizados en la Biblioteca Virtual de Salud (BVS): | Haga clic aquí para acceder a los documentos de la BVS | ||||||
Fecha de establecimiento: | 01/01/1983 | ||||||
Fecha de entrada: | 11/05/1982 | ||||||
Fecha de revisión: | 30/06/2005 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Lipids [D10]Lipids -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
Platelet Activating Factor
- Concepto preferido
UI del concepto |
M0017009 |
Nota de alcance | A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. |
Término preferido | Platelet Activating Factor |
Término(s) alternativo(s) |
1 Alkyl 2 acetyl sn glycerophosphocholine 1-Alkyl-2-acetyl-sn-glycerophosphocholine AGEPC Acetyl Glyceryl Ether Phosphorylcholine Aggregating Factor, Platelet Factor, Platelet Activating PAF Acether PAF-Acether Phosphorylcholine, Acetyl Glyceryl Ether Platelet Activating Substance Platelet Aggregating Factor Platelet Aggregation Enhancing Factor Platelet-Activating Substance Thrombocyte Aggregating Activity |
Queremos sus comentarios sobre el nuevo sitio web de DeCS / MeSH
Lo invitamos a completar una encuesta que no tomará más de 3 minutos.
Ir a la encuesta